Enanta Pharmaceuticals (ENTA) Change in Taxes (2014 - 2019)
Enanta Pharmaceuticals (ENTA) posted Change in Taxes of -$5.9 million for Q1 2019, down 231.05% on a QoQ basis from $4.5 million in Q4 2018, and down 20.11% year-over-year from -$7.3 million in Q1 2018.
Enanta Pharmaceuticals (ENTA) Change in Taxes (2014 - 2019) Analysis & Trends
Enanta Pharmaceuticals' Change in Taxes history runs 6 years deep, the most recent figure standing at -$5.9 million for Q1 2019.
- Quarterly Change in Taxes fell 20.11% year-over-year to -$5.9 million in Q1 2019, while the trailing twelve-month figure through Sep 2024 was -$5.9 million (changed N/A YoY) and the FY2025 annual result came in at $33.8 million, changed N/A from the prior year.
- Change in Taxes was -$5.9 million for Q1 2019 at Enanta Pharmaceuticals, down from $4.5 million in the prior quarter.
- Across five years, Change in Taxes topped out at $4.5 million in Q4 2018 and bottomed at -$12.3 million in Q2 2015.
- A 5-year average of -$1.9 million and a median of -$1.2 million in 2016 frame the typical range for Change in Taxes.
- Annual changes were most pronounced in 2015 — Change in Taxes sank 77.86% — and 2018, when it soared 366.11%.
- Enanta Pharmaceuticals' Change in Taxes stood at $3.7 million in 2015, then slumped by 132.24% to -$1.2 million in 2016, then soared by 179.52% to $959000.0 in 2017, then soared by 366.11% to $4.5 million in 2018, then slumped by 231.05% to -$5.9 million in 2019.
- Business Quant data shows ENTA's Change in Taxes at -$5.9 million in Q1 2019, $4.5 million in Q4 2018, and $1.4 million in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Enanta Pharmaceuticals | 376.07 Mn | 212.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | -5.86 Mn |
| Mar 31, 2019 | -5.86 Mn |
| Dec 31, 2018 | 4.47 Mn |
| Dec 31, 2018 | 4.47 Mn |
| Sep 30, 2018 | 1.39 Mn |
| Sep 30, 2018 | 1.39 Mn |
| Jun 30, 2018 | -5.38 Mn |
| Jun 30, 2018 | -5.38 Mn |
| Mar 31, 2018 | -4.88 Mn |
| Mar 31, 2018 | -4.88 Mn |
| Dec 31, 2017 | 959,000.00 |
| Dec 31, 2017 | 959,000.00 |
| Sep 30, 2016 | -1.21 Mn |
| Sep 30, 2016 | -1.21 Mn |
| Jun 30, 2016 | -4.29 Mn |
| Jun 30, 2016 | -4.29 Mn |
| Mar 31, 2016 | 2.31 Mn |
| Mar 31, 2016 | 2.31 Mn |
| Dec 31, 2015 | 3.74 Mn |
| Dec 31, 2015 | 3.74 Mn |